Paper
Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
Published Mar 29, 2021 · S. Bajaj, Maushmi S. Kumar, Hussain Tinwala
Bioorganic chemistry
Q1 SJR score
22
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro StudyStudy Snapshot
1,3,4-oxadiazole derivatives with substituted phenyl show potential as efficient thymidine phosphorylase enzyme inhibitors, with no signs of clinical toxicity observed.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.
1,3,4-oxadiazole derivatives show strong antimicrobial activity against a wide range of pathogenic bacteria, but do not target trans-translation in vivo, but rather act on other cellular pathways.
2019·28citations·Cédric Tresse et al.·Bioorganic & medicinal chemistry
Bioorganic & medicinal chemistry
Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles.
Lipophilic 1,3,4-oxadiazole derivatives show promising anticancer activity against 4T1 mammary carcinoma and CT26 colon cancer cells, with the most potent compounds inducing apoptosis induction.
2019·41citations·W. Caneschi et al.·European journal of medicinal chemistry
European journal of medicinal chemistry
Cancer statistics, 2019
The overall cancer death rate dropped from 1991 to 2016 by 27%, but socioeconomic inequalities remain, with mortality rates in poor counties being 2x higher for cervical cancer and 40% higher for male lung and liver cancers.
2019·17351citations·R. Siegel et al.·CA: A Cancer Journal for Clinicians
CA: A Cancer Journal for Clinicians
Diclofenac 1,3,4-Oxadiazole Derivatives; Biology-Oriented Drug Synthesis (BIODS) in Search of Better Non-Steroidal, Non-Acid Antiinflammatory Agents.
Diclofenac derivatives 4, 5, 11, 16, and 20 show promising antiinflammatory properties, with compound 5 being the most potent inhibitor of reactive oxygen species and nitric oxide production.
2018·18citations·S. Shah et al.·Medicinal chemistry (Shariqah (United Arab Emirates))
Medicinal chemistry (Shariqah (United Arab Emirates))
Citations
Insight into in vitro thymidine phosphorylase and in silico molecular docking studies: identification of hybrid thiazole bearing Schiff base derivatives.
Thiazole-hydrazone derivatives show potential as effective thymidine phosphorylase inhibitors, with compounds 12, 9, and 28 showing superior potency, suggesting potential applications in anticancer therapies.
2025·0citations·Sundas Mumtaz et al.·Zeitschrift fur Naturforschung. C, Journal of biosciences
Zeitschrift fur Naturforschung. C, Journal of biosciences
A Review on Synthesis and Biological Activities of Oxadiazole Derivatives
Oxadiazole heterocyclic compounds, when coordinated with suitable metals, show potential as antibacterial, anticancer, and antioxidant drugs.
2024·0citations·E. Ahmed et al.·Journal of Mines, Metals and Fuels
Journal of Mines, Metals and Fuels
A new N-acylhydrazone oxadiazole derivative with activity against mycobacteria.
The newly synthesized molecule (6n) shows anti-Mtb activity, low cytotoxicity, and selectivity for Mtb, making it a potential anti-TB drug candidate.
2024·0citations·Izabella Ventura Souza et al.·Future microbiology
Future microbiology
Design and synthesis of novel 2-(2-(4-bromophenyl)quinolin-4-yl)-1,3,4-oxadiazole derivatives as anticancer and antimicrobial candidates: in vitro and in silico studies
Novel quinoline-oxadiazole derivatives show promising anticancer and antimicrobial activity by inhibiting EGFR and microbial DNA gyrase, making them promising candidates for future optimization.
2024·0citations·Noha Ryad et al.·RSC Advances
RSC Advances
Synthesis, Antioxidant, and Anticancer Studies of New 1,3,4‐Oxadiazole Derivatives Linked to Benzoquinoline
New 1,3,4-oxadiazole derivatives synthesized show strong antioxidant and cytotoxic activities, with compounds 8 a, 8 b, and 13 showing strong cytotoxic activity.
2024·0citations·A. Fadda et al.·ChemistrySelect
ChemistrySelect
Design, Synthesis, in Vitro, and in Silico Evaluations of 1,3,4‐Oxadiazole Derivatives Linked to the Pyrrolo[2,3‐d]pyrimidine Moieties as Potent Antimicrobial Targets
1,3,4-oxadiazole derivatives linked to pyrrolo[2,3-d]pyrimidine moieties show excellent antimicrobial inhibitory activity, with compounds 6 f and 7 a showing potent antifungal activity against C. albicans.
2024·0citations·Jeevan Lal Patel et al.·ChemistrySelect
ChemistrySelect
Targeting Breast Cancer with Rationally Designed Quinazolines: A Scaffold Hopping Strategy
Compound 5h, a novel 4-anilinoquinazoline derivative, shows promising anticancer activity against MCF7 and MDA-MB-231 breast cancer cells, with more potent effects than FDA-approved erlotinib.
2024·1citation·Kwanshik Lee et al.·Journal of Molecular Structure
Journal of Molecular Structure